Fewer fractions of adjuvant external beam radiotherapy for early breast cancer are safe and effective and can now be the standard of care. Why the UK's NICE accepts fewer fractions as the standard of care for adjuvant radiotherapy in early breast cancer

Breast

Volumn 19, Issue 3, 2010, Pages 159-162

  Harnett, Adrian ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adjuvant radiotherapy; Early breast cancer; Fractionation; NICE guidelines

Indexed keywords

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; COST CONTROL; EARLY CANCER; EVIDENCE BASED MEDICINE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MASTECTOMY; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; THERAPY EFFECT; TREATMENT OUTCOME; UNITED KINGDOM; ADJUVANT THERAPY; BREAST NEOPLASMS; FEMALE; PATHOLOGY;

BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; GREAT BRITAIN; HUMANS; MASTECTOMY; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT;

EID: 77953356512     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.03.029     Document Type: Article

References (22)

1. National Institute for Health and Clinical Excellence Early and locally advanced breast cancer: diagnosis and treatment. (Clinical guideline) 2009, NICE, London.
2. Early Breast Cancer Trialists' Collaborative Group Radiotherapy for early breast cancer. Cochrane Database Syst Rev 2002, (2):CD003647. Art. No.: CD003647.
3. Morrow M., Strom E.A., Bassett L.W., Dershaw D.D., Fowble B., Giuliano A., et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002, 52:277-300.
4. Shelley W, Trudeau M. Cancer Care Ontario Practice Guidelines Initiative Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery. Practice Guideline Report; 2002. p. 1-2.
5. Overgaard M., Jensen M.B., Overgaard J., Hansen P.S., Rose C., Andersson M., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group. Lancet 1999, 353(9165):1641-1648.
6. Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? a subgroup analysis of the DBCG 82 b & c randomized trials. Radiother Oncol 2007, 82(3):247-253.
7. Ragaz J., Olivotto I.A., Spinelli J.J., Phillips N., Jackson S.M. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005, 97(2):116-126.
8. Department of Health Cancer reform strategy 2007, DoH, London.
9. Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision 2008, NICE interventional procedure guidance, National Institute for Health and Clinical Excellence, London, 268.
10. National Institute for Health and Clinical Excellence Advanced breast cancer: diagnosis and treatment. (Clinical guideline) 2009, NICE, London.
11. NICE website http://www.nice.org.uk.
12. Whelan T., MacKenzie R., Julian J., Levine M., Shelley W., Grimard L., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002, 94(15):1143-1150.
13. Yarnold J., Ashton A., Bliss J., Homewood J., Harper C., Hanson J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005, 75(1):9-17.
14. Owen J.R., Ashton A., Bliss J.M., Homewood J., Harper C., Hanson J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006, 7(6):467-471.
15. The START Trialists' Group The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9(4):331-341.
16. The START Trialists' Group The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371(9618):1098-1107.
17. Bates T.D. The 10-year results of a prospective trial of post-operative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma. Br J Radiol 1988, 61(727):625-630.
18. Goel A., Kaushal V., Hooda H.S., Das B.P. Comparison of two radiation dose schedules in post mastectomy carcinoma of the breast. Indian J Med Sci 2000, 54(7):278-283.
19. Taher A.N., El-Baradie M.M., Essa H., Zaki O., Ezzat S. Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Natl Canc Inst 2004, 16(3):178-187.
20. Williams M.V., James N.D., Summers E.T., Barrett A., Ash D.V. National survey of radiotherapy fractionation practice in 2003. Clin Oncol 2006, 18:3-14.
21. Williams M.V., Drinkwater K.J. Radiotherapy in England in 2007: modelled demand and audited activity. Clin Oncol 2009, 21:575-590.
22. Yarnold J. Personnel communication. Advances in radiotherapy: Head and Neck cancer and breast cancer. Newcastle; October 2009.